Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Completion Rates for Ecological Momentary Assessments of Food Intake During Pregnancy and Post Partum: Descriptive Study.

JMIR human factors·2025
Same author

Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicity.

mBio·2025
Same author

African American Fathers as a Solution to the Maternal Health Crisis.

Social work in public health·2024
Same author

Overview of U.S. COVID-19 vaccine safety surveillance systems.

Vaccine·2024
Same author

COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion.

American journal of epidemiology·2023
Same author

Doris Duke Charitable Foundation Fund to Retain Clinical Scientists: innovating support for early-career family caregivers.

The Journal of clinical investigation·2022

Related Experiment Video

Updated: Jun 22, 2026

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

Obesity in pregnancy.

Esa Davis1, Christine Olson

  • 1Department of Family Medicine, Case Western Reserve University, 11001 Cedar Avenue, Cleveland, OH 44106, USA. esa.davis@case.edu

Primary Care
|June 9, 2009
PubMed
Summary

Childbearing can lead to long-term obesity in women. Managing prepregnancy weight, pregnancy weight gain, and postpartum weight is crucial for maternal health and preventing obesity.

Area of Science:

  • Reproductive Health
  • Obesity Research
  • Maternal-Child Health

Background:

  • Childbearing is a significant factor in the long-term development of obesity among women.
  • High prepregnancy weight, excessive gestational weight gain, and postpartum weight retention are identified risk factors for maternal obesity.
  • Maternal obesity poses risks for both the mother and the infant, increasing morbidity and mortality.

Purpose of the Study:

  • To highlight the contribution of childbearing to long-term obesity in women.
  • To identify key factors during and after pregnancy that influence obesity risk.
  • To propose educational interventions for managing weight during and after pregnancy.

Main Methods:

  • This study is a review of existing literature on childbearing and obesity.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Related Experiment Videos

Last Updated: Jun 22, 2026

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

  • Analysis of risk factors including prepregnancy weight, pregnancy weight gain, and postpartum weight retention.
  • Examination of the impact of maternal obesity on maternal and infant health outcomes.
  • Main Results:

    • Childbearing is a critical period associated with the onset and exacerbation of obesity in women.
    • Specific weight-related factors during pregnancy and postpartum are strongly linked to future obesity.
    • Maternal obesity has significant adverse effects on maternal and infant health.

    Conclusions:

    • Interventions focusing on appropriate pregnancy weight gain and postpartum weight loss are essential.
    • Educating women on weight management strategies during the childbearing years may help mitigate the rise in obesity.
    • Addressing weight management around childbearing is vital for public health initiatives targeting obesity reduction.